147 related articles for article (PubMed ID: 18348079)
1. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
Tews D; Werner U; Eckel J
Horm Metab Res; 2008 Mar; 40(3):172-80. PubMed ID: 18348079
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
3. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4 protects murine pancreatic β-cells from free fatty acid-induced apoptosis through PI-3K signaling.
Liu L; Wang Y; Wang L; Lin Y; Liu X; Liu X; Liu L
Endocr Res; 2013; 38(1):40-7. PubMed ID: 22913774
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway.
Ferdaoussi M; Abdelli S; Yang JY; Cornu M; Niederhauser G; Favre D; Widmann C; Regazzi R; Thorens B; Waeber G; Abderrahmani A
Diabetes; 2008 May; 57(5):1205-15. PubMed ID: 18252896
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
8. Effect of PANDER in βTC6-cell lipoapoptosis and the protective role of exendin-4.
Xiang JN; Chen DL; Yang LY
Biochem Biophys Res Commun; 2012 May; 421(4):701-6. PubMed ID: 22542939
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria.
Tews D; Lehr S; Hartwig S; Osmers A; Paslack W; Eckel J
Horm Metab Res; 2009 Apr; 41(4):294-301. PubMed ID: 19085810
[TBL] [Abstract][Full Text] [Related]
10. Role of ERp46 in β-cell lipoapoptosis through endoplasmic reticulum stress pathway as well as the protective effect of exendin-4.
Chen DL; Xiang JN; Yang LY
Biochem Biophys Res Commun; 2012 Sep; 426(3):324-9. PubMed ID: 22935416
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.
Li L; El-Kholy W; Rhodes CJ; Brubaker PL
Diabetologia; 2005 Jul; 48(7):1339-49. PubMed ID: 15902400
[TBL] [Abstract][Full Text] [Related]
12. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
13. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Neumiller JJ
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
[TBL] [Abstract][Full Text] [Related]
14. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
16. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
Uhles S; Wang H; Bénardeau A; Prummer M; Brecheisen M; Sewing S; Tobalina L; Bosco D; Wollheim CB; Migliorini C; Sebokova E
Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.
Cunha DA; Ladrière L; Ortis F; Igoillo-Esteve M; Gurzov EN; Lupi R; Marchetti P; Eizirik DL; Cnop M
Diabetes; 2009 Dec; 58(12):2851-62. PubMed ID: 19720788
[TBL] [Abstract][Full Text] [Related]
18. Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.
Baden MY; Fukui K; Hosokawa Y; Iwahashi H; Imagawa A; Shimomura I
PLoS One; 2015; 10(12):e0144606. PubMed ID: 26659307
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
20. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
Bregenholt S; Møldrup A; Blume N; Karlsen AE; Nissen Friedrichsen B; Tornhave D; Knudsen LB; Petersen JS
Biochem Biophys Res Commun; 2005 May; 330(2):577-84. PubMed ID: 15796922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
